MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Dandy-Walker syndrome. A case study.

    GM. Mussagaliyeva (Almaty, Kazakhstan)

    Objective: Present a case study with rare congenital disease for further сreating a database and developing algorithms for the management of such cases in the…
  • 2024 International Congress

    Deep Brain Stimulation for Primary Refractory Tinnitus: A Systematic Review

    L. Basner, D. Zeitler, S. Schwartz, A. Bansal, K. Krause, F. Farrokhi (Seattle, USA)

    Objective: This literature review aims to investigate the efficacy and safety of deep brain stimulation for primary refractory tinnitus. It seeks to describe the current…
  • 2024 International Congress

    Triple threat: A rare case of a patient with 3 co-existent autoimmune antibodies causing autonomic and movement disorder

    YK. Kim, KC. Colletta (Maywood, USA)

    Objective: We describe a unique case of a patient with a constellation of movement and autonomic abnormalities. Serum paraneoplastic/autoimmune testing was positive for 3 separate…
  • 2024 International Congress

    Preventing Medication Errors for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention

    C. Piccinin, J. Yu, A. Brooks, V. Stepanyants, P. Clark, S. Shaffer, B. Sokola, K. Lewin, C. Sonneborn, O. Hogue, S. Sperling, H. Fernandez, W. Walter (Cleveland, USA)

    Objective: To determine whether a Parkinson’s disease (PD) Inpatient Program will prevent medication errors and ultimately improve the safety and quality of care for hospitalized…
  • 2024 International Congress

    Utility of Serum α-synuclein Seed Amplification Assay as a Parkinson’s Disease Biomarker

    S. Mosovsky, A. Okuzumi, C. Adler, T. Beach, T. Foroud, G. Serrano, J. Eberling, L. Oliveira, T. Hatano, N. Hattori, B. Mollenhauer, L. Chahine (Pittsburgh, USA)

    Objective: To determine the sensitivity and specificity of serum α-synuclein seed amplification assay (SAA) for Parkinson’s disease (PD) diagnosis in the Systemic Synuclein Sampling Study…
  • 2024 International Congress

    Lingual-Masticatory Myorhythmia and Palatal Tremor as a Presentation of Anti-IgLON5 Disease

    RY. Wu, CC. Hsieh, YT. Sun, TL. Lee (Tainan, Taiwan)

    Objective: Anti-immunoglobulin-like cell adhesion molecule-5 (anti-IgLON5) disease may manifest with spectrum of various neurological presentations and movement disorders, including prominent sleep movement disorders, bulbar symptoms,…
  • 2024 International Congress

    Opportunities for Medical Knowledge Self-Assessment in Movement Disorder Fellowship

    A. Higinbotham, A. Wang, A. Toth, C. Kilbane (Charlottesville, USA)

    Objective: To determine 1) what opportunities for medical knowledge self-assessment exist in movement disorder fellowship training, 2) how satisfied fellows are with such opportunities, and…
  • 2024 International Congress

    Autosomal Recessive GTPCH Deficiency: Redefining the Phenotypic Spectrum and Outcome

    M. Novelli, M. Tolve, V. Quiroz, C. Carducci, R. Bove, G. Ricciardi, C. Yang, F. Pisani, D. Ebrahimi-Fakhari, S. Galosi, V. Leuzzi (Rome, Italy)

    Objective: To describe the clinical phenotype of autosomal recessive GTP cyclohydrolase deficiency (ARGTPCHD), its genetic and metabolic correlates, and their possible predictive value through a…
  • 2024 International Congress

    Therapeutic challenges of long-standing chelator therapy in Wilson’s Disease

    C. Guedes Vaz, H. Pessegueiro, J. Castro Ferreira, J. Gandara, V. Dionísio Lopes, E. Silva, S. Ferreira, C. Pereira, D. Valadares, L. Maia, J. Presa, A. Pinto, A. Costa, C. Rolanda, C. Agostinho, I. Gonçalves, P. Peixoto, R. Costa, S. Lopes, M. Magalhães (Porto, Portugal)

    Objective: To determine the frequency of side effects of long-term copper chelation therapy in Wilson’s disease (WD). Background: WD is a neurometabolic autosomal recessive disorder…
  • 2024 International Congress

    Movement Disorder Presentations in Leukoenephalopathy with Calcifications and Cysts

    L. Tochen, J. Harmon, J. Rhee, J. Fraser (Washington, USA)

    Objective: The aim of this study is to describe the movement disorder phenotypes within a cohort of individuals with Leukoencephalopthy with Calcifications and Cysts. Background:…
  • « Previous Page
  • 1
  • …
  • 529
  • 530
  • 531
  • 532
  • 533
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley